Healthtech Startups
18,423 companies tagged Healthtech, with their investors and founders.
AppliedVR develops immersive therapeutic software using technology to deliver drug-free clinical treatments for patients. The company focuses on healthcare applications where traditional medical approaches have limitations.
6 investors
Apploi provides recruitment marketing and hiring software for healthcare facilities, including job board distribution, mobile-optimized applications, branded career pages, and candidate texting. Its platform also covers scheduling, onboarding, and shift management for healthcare staffing.
6 investors
Archy builds a unified software platform for dental practices that integrates scheduling, patient management, and practice operations. The product serves dental offices and their teams across the U.S., eliminating fragmented systems and improving workflow efficiency.
6 investors
The company develops therapies for people with severe autoimmune diseases.
6 investors
6 investors
Arogga is an online pharmacy in Bangladesh selling prescription and OTC medicines, healthcare devices, beauty, baby care, and wellness products, with prescription verification by licensed pharmacists and nationwide home delivery. It also offers home lab-test sample collection and online doctor consultations for consumers across all 64 districts of Bangladesh.</parameter> <parameter name="founders">[]
6 investors
Arpeggio Bio develops pharmaceutical drugs that target transcription factors using artificial intelligence and RNA-sequencing technology, with lead programs in development for melanoma treatment and rare disease applications.
6 investors
Array Behavioral Care is a virtual psychiatry and therapy practice that delivers integrated behavioral health services from hospitals to homes. It partners with hospitals, medical groups, clinics, and payors to expand access to mental health care across the United States.
6 investors
Arrive Health provides in-workflow software that gives clinical care teams real-time insurance, medication cost, and coverage data plus automation for prior authorization and patient outreach. The tools aim to improve medication affordability, time to therapy, and adherence while reducing phone calls and faxes.
6 investors
Arrow provides AI-powered tools for revenue cycle management (RCM) teams in healthcare to automate billing tasks and improve collections efficiency. The platform combines AI automation with human expertise to reduce administrative work and allow billing professionals to focus on high-value revenue collection strategies.
6 investors
Artera develops AI-powered diagnostic tests that analyze patient biopsy images to predict therapeutic response in cancer care. The company enables personalized treatment decisions and shared decision-making between clinicians and patients, beginning with localized prostate cancer.
6 investors
ShipArty builds IoT-enabled temperature-controlled containers and software platform to reduce cold chain spoilage for medicines, vaccines, and other temperature-sensitive products. The company offers reusable, sustainable alternatives to single-use cooling systems for pharmaceutical and healthcare supply chains.
6 investors
Nashville-based provider of home and outpatient community-based palliative care for seriously ill patients, acquired by Anthem in 2018.
6 investors
Ataraxis develops AI foundation models that analyze multi-modal patient data, including pathology slide images, to assess cancer aggressiveness and predict recurrence risk and treatment response. Its first product, Ataraxis Breast, provides clinically validated prognostic and predictive tools for breast cancer patients and their physicians.
6 investors
Authenticx is a conversation intelligence platform that uses AI trained on healthcare data to uncover system-critical insights from customer interactions, helping healthcare organizations identify barriers to better outcomes and improve operational efficiency.
6 investors
Auxilius provides software and expert services to manage clinical R&D operations and financial processes for biotech companies. The platform automates budgeting, forecasting, and financial close procedures to reduce clinical trial failures caused by operational complexity.
6 investors
Avedro is an ophthalmic company focused on corneal health, known for bio-activated cross-linking therapies such as the KXL system and riboflavin-based treatments used to address progressive keratoconus. It was acquired in 2019 by Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company developing glaucoma, corneal and retinal therapies, and now operates as part of Glaukos, whose website the avedro.com domain serves.
6 investors
Avi Medical operates a network of primary care practices across Germany offering preventive medicine and general medical services. The company employs medical professionals to deliver patient care at multiple clinic locations.
6 investors
AVIA operates a network and advisory platform for health systems, providing benchmarking, market intelligence, and peer collaboration to support their digital transformation and AI adoption. It serves hospitals and health systems and includes offerings like AVIA Marketplace and Panda Health for evaluating digital health companies.
6 investors
AviadoBio is a gene therapy company developing adeno-associated viral (AAV) treatments for neurodegenerative disorders such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). It is a spinout from King's College London research focused on the genetics and molecular biology of these diseases.
6 investors
AVTTX is a clinical-stage company developing gene therapy treatments for retinal and ophthalmologic diseases. The company leverages adeno-associated virus (AAV) technology to address unmet medical needs in vision care.
6 investors
Azafaros is a clinical-stage biopharmaceutical company developing small-molecule therapies for severe rare genetic metabolic disorders, including GM1/GM2 gangliosidoses, Niemann-Pick type C disease, and other conditions. The company's lead program, nizubaglustat, is currently in Phase 3 trials.
6 investors
A provider of youth and family behavioral and mental health services, offering cognitive talk therapy and medication management through licensed clinicians including psychologists, counselors, and psychiatric nurse practitioners.
6 investors
Baebies develops multifunctional syndromic diagnostic testing using proprietary digital microfluidics, integrating molecular, immunoassay, chemistry, and coagulation testing into a single compact platform (FINDER) that runs on small-volume samples. Its products serve hospitals, clinics, pharmacies, and decentralized care settings for patients of all ages, having started with newborn and pediatric diagnostics.
6 investors














